DC72365 |
BAY-390
|
BAY-390 is a selective, across species active and brain penetrating TRPA1 inhibitor. BAY-390 inhibits hTRPA1 FLIPR, hTRPA1 Ephys, rTRPA1 FLIPR and rDRG Ephys with IC50s of 16, 82, 63 and 35 nM, respectively. |
DC70461 |
GSK3527497
|
GSK3527497 (GSK-3527497) is a potent, selective TRPV4 inhibitor with IC50 of 12 nM (hTRPV4).GSK3527497 is a pre-clinical candidate for treatment of diseases resulting from TRPV4 activation. |
DC70460 |
GSK3395879
|
GSK3395879 (GSK-3395879) is a novel potent, selective, orally bioavailable antagonist of TRPV4 with IC50 of 1 nM (hTRPV4); exhibits little or no activity against a broad panel of TRP channels (IC50 > 10µM for TRPA1, TRPV1, TRPM2, TRPM4, TRPM8, TRPC3, TRPC4, TRPC5, TRPC6); demonstrates the ability to inhibit TRPV4-mediated pulmonary edema in an in vivo rat model. |
DC11472 |
TRPM8 antagonist 14
|
TRPM8 Antagonist is a potent and selective TRPM8 antagonist, with an IC50 of 0.2 nM, used in the research of neuropathic pain syndromes. |
DC7755 |
TRCP6 inhibitor(SAR7334)
|
TRPC6 inhibitor is a potent TRPC6(Transient receptor potential cation channel, subfamily C, member 6) inhibitor. |
DC9722 |
SKF96365
|
SKF96365 is blocker of TRP cation channels. Inhibits capacitative Ca2+ entry. |
DC9635 |
SB-705498
|
SB-705498 is a potent, selective and orally bioavailable transient receptor potential vanilloid 1 (TRPV1) receptor antagonist with a pIC50 of 7.1. |
DC9735 |
SB-366791
|
SB-366791 is a selective and competitive VR1 (TRPV1) antagonist that is commonly used in pain research. |
DC8306 |
RQ-00203078
|
RQ-00203078 is a potent TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively). |
DC7262 |
Optovin
|
Optovin is a reversible photoactive TRPA1 activator. |